Atlas Trials

Immune Response to Third Dose of SARS-CoV-2 Vaccine in a Cohort of Cancer Patients on Active Treatment

Clinical trial NCT05119738 · UNKNOWN

Trial details

NCT number
NCT05119738
Sponsor
Pontificia Universidad Catolica de Chile
Status
UNKNOWN
Study type
OBSERVATIONAL
Sars-CoV-2 Infection
Start date
2021-10-27
Primary completion
2022-03-01
Enrollment
122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.